Tuesday, May 30, 1995
Gallo's corporate plans
Robert Gallo, who is leaving the NIH to lead the Institute of Human Virology at the
University of Maryland, also plans to create a biotech company to link his highly academic
research to the clinic.
In an interview with BioCentury after announcing his planned departure from the NIH
last week, Gallo sketched out his model for an associated biotechnology company,Virex,
where he expects to be chief scientific advisor.